In the current study, we have explored the mutational spectrum of 26 well-established cancer-related genes and ALK, RET, and ROS1 gene fusions by massive parallel sequencing in a large panel of thoroughly histopathologically classified primary LC and LCNEC lung cancers. The gene discussed is ROS1; the disease is large cell neuroendocrine carcinoma.